LNTH News and Press, Lantheus Holdings Inc. From 03/01/21

OSPREY Phase 2/3 Results Published in the Journal of Urology CONDOR Phase 3 Results Published in Clinical Cancer Research Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics,...

Lantheus Holdings, Inc. (LNTH) Q4 2020 Earnings Conference Call February 25, 2021 04:30 PM ET Company Participants Mark Kinarney - Senior Director of Investor Relations Mary Anne Heino - President and CEO Bob Marshall - Chief Financial Officer Conference Call Participants Anthony Petrone - Je...

The following slide deck was published by Lantheus Holdings, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Lantheus Holdings, Inc. 2020 Q4 - Results - Earnings Call Presentation

Image source: The Motley Fool. Lantheus Holdings Inc (NASDAQ: LNTH) Q4 2020 Earnings Call Feb 25, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Lantheus Holdings Inc (LNTH) Q4 2020 Earnings Call Transcript

Lantheus (LNTH): Q4 Non-GAAP EPS of $0.07 beats by $0.06; GAAP EPS of -$0.05.Revenue of $94.2M (+5.4% Y/Y) beats by $2.79M.Press Release For further details see: Lantheus EPS beats by $0.06, beats on revenue

Worldwide revenue of $94.2 million and $339.4 million for the fourth quarter and full year 2020, representing an increase of 5.4% and a decline of 2.3% over the prior year period, respectively Net loss of $3.4 million and $13.5 million for the fourth quarter and full yea...

Lantheus (NASDAQ:LNTH) is scheduled to announce Q4 earnings results on Thursday, February 25th, after market close.The consensus EPS Estimate is $0.01 (-97.1% Y/Y) and the consensus Revenue Estimate is $91.41M (+2.3% Y/Y).Over the last 2 years, LNTH has beaten EPS estimates 100% of the time a...

Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find, Fight and Follow serious medical conditions, today announced Mary Anne Heino...

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 4:30 p.m. ET on Thursday, February 25, 2021, to discuss its financial and operating results for the fourth quarter and full year of 2020. To ac...

Lantheus Holdings, Inc. (NASDAQ: LNTH) (the “Company”), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic agents and p...